Related references
Note: Only part of the references are listed.Inhibition of Nogo-A rescues synaptic plasticity and associativity in APP/PS1 animal model of Alzheimer's disease
Maria Vazquez Pavon et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2023)
Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis
Belgin Sever et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2
Caitlin M. Rodriguez et al.
CELL REPORTS (2022)
LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury
Shuhei Ito et al.
STEM CELL REPORTS (2021)
Axonal regeneration and functional recovery driven by endogenous Nogo receptor antagonist LOTUS in a rat model of unilateral pyramidotomy
Ryu Ueno et al.
EXPERIMENTAL NEUROLOGY (2020)
Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury
Xingxing Wang et al.
BRAIN (2020)
Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy
Marc-Olivier Deguise et al.
EBIOMEDICINE (2020)
Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model
Kevin A. Guttenplan et al.
NATURE COMMUNICATIONS (2020)
Challenges of BDNF-based therapies: From common to rare diseases
Catarina Miranda-Lourenco et al.
PHARMACOLOGICAL RESEARCH (2020)
Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation
Keita Takahashi et al.
JOURNAL OF NEUROINFLAMMATION (2018)
LOTUS Inhibits Neuronal Apoptosis and Promotes Tract Regeneration in Contusive Spinal Cord Injury Model Mice
Shuhei Ito et al.
ENEURO (2018)
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
Vincent Meininger et al.
LANCET NEUROLOGY (2017)
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Lindsay A. Becker et al.
NATURE (2017)
LOTUS overexpression accelerates neuronal plasticity after focal brain ischemia in mice
Hajime Takase et al.
PLOS ONE (2017)
Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS
Tomoko Hirokawa et al.
SCIENTIFIC REPORTS (2017)
The Nogo/Nogo Receptor (NgR) Signal Is Involved in Neuroinflammation through the Regulation of Microglial Inflammatory Activation
Yinquan Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis
Keita Takahashi et al.
JAMA NEUROLOGY (2015)
Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients
Gaelle Bruneteau et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
The Role of Chondroitinase as an Adjuvant to Peripheral Nerve Repair
Trenton M. Gause et al.
CELLS TISSUES ORGANS (2014)
Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy
Nicolas T. Lindau et al.
BRAIN (2014)
Nogo limits neural plasticity and recovery from injury
Martin E. Schwab et al.
CURRENT OPINION IN NEUROBIOLOGY (2014)
Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis
Virginie Bros-Facer et al.
HUMAN MOLECULAR GENETICS (2014)
LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand
Yuji Kurihara et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2014)
Multiple Sclerosis: Does Nogo Play a Role?
Jae Young Lee et al.
NEUROSCIENTIST (2013)
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation
Steven Petratos et al.
BRAIN (2012)
Scar-mediated inhibition and CSPG receptors in the CNS
Kartavya Sharma et al.
EXPERIMENTAL NEUROLOGY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans
Travis L. Dickendesher et al.
NATURE NEUROSCIENCE (2012)
Recovery from chronic spinal cord contusion after nogo receptor intervention
Xingxing Wang et al.
ANNALS OF NEUROLOGY (2011)
Effect of Three Types of Mixed Anesthetic Agents Alternate to Ketamine in Mice
Sumiko KAWAI et al.
EXPERIMENTAL ANIMALS (2011)
Blockade of Gap Junction Hemichannel Suppresses Disease Progression in Mouse Models of Amyotrophic Lateral Sclerosis and Alzheimer's Disease
Hideyuki Takeuchi et al.
PLOS ONE (2011)
Cartilage Acidic Protein-1B (LOTUS), an Endogenous Nogo Receptor Antagonist for Axon Tract Formation
Yasufumi Sato et al.
SCIENCE (2011)
MAG and OMgp Synergize with Nogo-A to Restrict Axonal Growth and Neurological Recovery after Spinal Cord Trauma
William B. J. Cafferty et al.
JOURNAL OF NEUROSCIENCE (2010)
Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury
Irin C. Maier et al.
BRAIN (2009)
Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis
Felicia Yu Hsuan Teng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Accumulation of chondroitin sulfate proteoglycans in the micro environment of spinal motor neurons in amyotrophic lateral sclerosis transgenic rats
Hideki Mizuno et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
A role for Nogo receptor in macrophage clearance from injured peripheral nerve
Elizabeth J. Fry et al.
NEURON (2007)
The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model
Natasa Jokic et al.
EMBO REPORTS (2006)
Onset and progression in inherited ALS determined by motor neurons and microglia
Severine Boillee et al.
SCIENCE (2006)
Myelin-associated inhibitors regulate cofilin phosphorylation and neuronal inhibition through LIM kinase and slingshot phosphatase
SHK Hsieh et al.
JOURNAL OF NEUROSCIENCE (2006)
Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity
N Jokic et al.
ANNALS OF NEUROLOGY (2005)
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS
MT Filbin
NATURE REVIEWS NEUROSCIENCE (2003)
Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth
V Kottis et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis
L Dupuis et al.
NEUROBIOLOGY OF DISEASE (2002)
Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1
MS Chen et al.
NATURE (2000)
Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein
T GrandPré et al.
NATURE (2000)
Share Paper
